REFRACTORY PANCREATIC CARCINOMA

Clinical trials for REFRACTORY PANCREATIC CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY PANCREATIC CARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY PANCREATIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug duo targets Tough-to-Treat cancers

Disease control Recruiting now

This study is testing the safety and effectiveness of a new two-drug combination for people with advanced solid tumors, including pancreatic cancer, that have spread or stopped responding to standard treatments. The trial aims to find the best dose and see if the drugs can help c…

Matched conditions: REFRACTORY PANCREATIC CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

REFRACTORY PANCREATIC CARCINOMA

Get alerted when new REFRACTORY PANCREATIC CARCINOMA trials appear

New drug duo targets Tough-to-Treat cancers